NRx Pharmaceuticals, Inc. (NRXPW)
NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.0901
-0.0068 (-7.02%)
May 12, 2025, 4:00 PM - Market closed
-7.02%
Market Cap 34.51M
Revenue (ttm) n/a
Net Income (ttm) -25.13M
Shares Out 16.92M
EPS (ttm) -2.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,401
Open 0.0901
Previous Close 0.0969
Day's Range 0.0901 - 0.0901
52-Week Range 0.0598 - 0.0686
Beta 1.45
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2025

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

Financial Performance

News

There is no news available yet.